Helps you take the hassle out of diabetes management.
Easy blood glucose readings with

Contour Next One


App Resized

The unique smartLIGHT feature
With one flash of coloured light, you know whether you’re within,
above, or below your target range.







Convenient App 
The FREE CONTOUR® DIABETES App is intuitive and can help make your diabetes management easier.
Learn more

App Resized
App Store Button
Google Play Button
Connected with Apple HealthTM
second use

May Help Prevent Wasted Strips1,2
Second-Chance® Sampling gives you 60 seconds to reapply blood to the same strip.

Choose Accuracy
The CONTOUR® NEXT ONE smart meter has been shown to deliver remarkable accuracy within ±8.4% of a lab reading.‡,¤,§




Helps you take the hassle out of
diabetes management

Box Resize



Learn more about CONTOUR® NEXT ONE

Disclaimer:  * with purchase of CONTOUR®NEXT Test Strips † Patient should consult with health care provider before making any changes to blood glucose target ranges, diet, treatment, or exercise decisions. The CONTOUR®NEXT ONE meter pre-set target ranges may be changed using the CONTOUR®DIABETES App. Always review your blood glucose readings in conjunction with the coloured light before making any adjustments to treatment, diet and exercise.

Footnotes:  ‡ Current regulation based on Health Canada recognized ISO 15197:2013 standard requires results within ±15% range, specifically: ≥95% of results must fall within ±0.83 mmol/L for blood glucose concentrations <5.55 mmol/L and within ±15% for blood glucose concentrations ≥5.55 mmol/L. ¤ CONTOUR®NEXT ONE meter meets ±10% accuracy vs. laboratory method, specifically: 97.4% of results within ±10% for blood glucose concentrations ≥5.55 mmol/L, and 100% of results within ±0.56 mmol/L accuracy vs. laboratory method for blood glucose concentrations <5.55 mmol/L. § In a clinical study, conducted in accordance with the requirements of ISO 15197:2013, the CONTOUR®NEXT ONE not only met and exceeded the minimum requirements of the standard but an ad hoc analysis determined where 95% of results fell during the study, which was within ±0.47 mmol/L or ±8.4% of the laboratory reference value for glucose concentrations <5.55 mmol/L or ≥5.55 mmol/L, respectively, when tested via subject obtained capillary fingertip results (patients with diabetes).

References: 1. Ascensia Diabetes Care. Data on file. Market Research. Hall & Partners, conducted online April/May 2015. 2. Ascensia Diabetes Care. Data on file. Average strip wastage estimated by healthcare professionals. Data and quotes collected through online survey of 400 HCPs and patient with Diabetes in US, CAN, DE and UK.

Ascensia, the Ascensia Diabetes Care logo, Contour, Microlet, Glucofacts, the No Coding logo, and Second-Chance are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG.

Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google Inc. The BluetoothTM word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Ascensia Diabetes Care is under license. All other trademarks are the property of their respective owners. For a full list of trademarks click here.

© Copyright 2019 Ascensia Diabetes Care Canada Inc.. Published by Ascensia Diabetes Care Canada Inc, 2920 Matheson Blvd East, Mississauga, Ontario, L4W 5R6, Canada. Tel: 1-800-268-7200

®TM see